AIIMS Issues Notice On OBC-NCL & EWS Eligibility for INI-CET January 2025 Seat Allocation
Delhi : Through a recent notice, All India Institute of Medical Sciences (AIIMS) has informed on the OBC-NCL & EWS Eligibility for INI-CET January 2025 Seat Allocation.
"In compliance with the Hon’ble Delhi High Court judgment in W.P. (C) No. 15514/2023, Ravi Kumar v. AIIMS, upheld by the Hon’ble Division Bench of the Delhi High Court and the Hon’ble Supreme Court of India, candidates under the OBC-NCL and EWS categories who submitted valid certificates within the extended timeline are eligible to participate in the online seat allocation for the INI-CET January 2025 session", the notice informed
"Accordingly, all eligible candidates can exercise choices latest by 05.00 PM 18.12.2024. Those who have already exercised choice can edit by the 05.00 PM of 18.12.2024. All candidate becoming eligible have been informed by email and are advised to check their email. No further opportunity will be granted to exercise choices," the notice added
The link for the portal will be activated only for eligible candidates on “MyPage” accessible by logging in using the credentials that have been used for filling completion of application form and other processes related to INI-CET for admission to PG courses for January 2025 session in AIIMS Website.
All other terms and conditional mentioned in Notice No. 156/2024 dated 28.11.2024 remains same.
To view the official Notice, Click here : https://medicaldialogues.in/pdf_upload/1noticechoicereopeninicetjan25-265174.pdf
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.